Exhibit 99.1 FOR IMMEDIATE RELEASE Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results Fourth Quarter 2024 Financial Results Summary: Fiscal Year 2024 Financial Results Summary: • Net revenue of 126.7millionforthefourthquarterof2024,anincreaseof27.0 million compared to net revenue of 99.7millionforthefourthquarterof2023.Netrevenueforthefourthquarterof2024consistsof:oNetrevenuefromAdvancedWoundCareproductsof118.6 million, an increase of 27% from ...